Articles

P.14.2 KIT D816 mutation in myeloid neoplasms: look out for systemic mastocytosis associated hematologic neoplasms (SM-AHN)

BJH - volume 11, issue Abstract Book BHS, february 2020

E. Linskens , S. Van Landeghem , K. Vandepoele PhD, dr. K. Maes , I. Moors MD, dr. J. Van Dorpe , C. Bonroy , K. Devreese , J. Philippé MD, PhD, B. Denys MD

Read more

P.42 Acquired von Willebrand disease following marginal zone lymphoma relapse: a case report

BJH - volume 11, issue Abstract Book BHS, february 2020

F. Verbeke , P. Decruyenaere , P. Vlummens MD, A. Vantilborgh , K. Devreese

Read more

P12 SENSITIVITY OF THE NEW STAGO PT STA-NEOPTIMAL REAGENT FOR FACTOR DEFICIENCY ON STAGO STA-R EVOLUTION

BJH - 2019, issue ?, february 2019

L. Florin , P. De Kesel , K. Devreese

Read more

P10 METHOD VALIDATION OF THE NEW STAGO PT REAGENT STANEOPTIMAL FOR PT/INR MEASUREMENT

BJH - 2019, issue ?, february 2019

L. Florin , P. De Kesel , K. Devreese

Read more

A-104 THE INTERACTION OF FACTOR V AND TISSUE FACTOR PATHWAY INHIBITOR IN A MYELOMA PATIENT WITH ACQUIRED FACTOR V DEFICIENCY

BJH - volume 9, issue Abstract Book BSTH, february 2018

E. De Maertelaere , E. Castoldi , I. Van Haute , D. Deeren MD, K. Devreese

Read more
X